Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CMSS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PPP3CB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIMM23B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PRDM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USMG5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAN2A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNPY2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WLS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMED5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP4R2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NSMCE4A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASP7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TM9SF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDX20 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAA50 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YES1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPL35A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SFXN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCGF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on